Biotech Finance News

Biotech Stock News: A Look At All the Biotech Stocks For the Past Week

Last week, companies like Sunesis Pharmaceuticals, Inc (SNSS) and Chimerix, Inc (CMRX) were in the news due to pipeline updates. While Sunesis’ shares slumped on disappointing data, Chimerix made news related to the Ebola virus. Meanwhile, Regeneron’s (REGN) Eylea continues to gain approval for new indications. Sunesis’ shares tanked 78% on news that a pivotal…

Read More

STERV Sees Loss in Paper and Writing Segment

In the second quarter, Finnish forest products company Stora Enso had a surprising loss in its Paper and Writing segment. Even though the secular headwinds for publishing paper in Europe are well known, Stora had previously been able to turn a consistent profit in the business in recent years. Management says it is stepping up…

Read More
Biotech Stock Finance Bio Tech

Biotech Stock News: Regeneron’s Eylea Gets An Important Approval From FDA

Good news flowed in at Regeneron Pharmaceuticals (REGN) when the FDA cleared the company’s highly successful injectable eye drug for macular edema following retinal vein occlusion (RVO), a common retinal vascular disorder. Approval for the broad RVO indication includes sub-indications like, macular edema following branch retinal vein occlusion (BRVO) and macular edema following central retinal…

Read More

CF Industries Continues to Boast Solid Earnings in Q2

CF Industries reported second-quarter results that were generally in line with analysts’ expectations. Nitrogen volumes were up 2.2% year over year as the nitrogen application season in North America finished at a rapid pace following delays to planting caused by wet weather in the Corn Belt. Last season, warm weather in the spring pulled planting…

Read More